-
to leverage myeloid cells for cancer therapy. In support of this we previously found combinatory myeloid activation to drive tumor eradication in mouse models of PDA (Wattenberg et al. Science Immunology. 2023
-
in adaptive immune systems (e.g., co-evolution of bacteria and phages, as well as T and B cells with pathogens). • Physics-informed machine learning of biophysical systems (e.g., developing optimal
-
). Designs experiments employing immunologic assays and GVHD/GVT models to evaluate invariant natural killer T cell function. Optimizes transgene delivery to engineer invariant natural killer T cells
-
with optimization, data science, and analytic techniques, including time series analysis. Record of mentoring and developing junior employees on soft and technical skills. Advanced experience with